PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

BMS Opdivo-Yervoy combo fails in kidney cancer trial

Bristol Myers Squibb's kidney cancer drug yielded disappointing trial results when used as a post-surgery combination treatment for patients with loca...
Continue Reading →
News

Ipsen inks deal to take two Marengo oncology drugs to the clinic

Ipsen and Marengo Therapeutics announced a strategic partnership to advance two of Marengo’s preclinical STAR platform-generated candidates into the clinic...
Continue Reading →
News

Novo Nordisk once-weekly insulin hits phase 3 goals

Novo Nordisk announced positive headline results from a pair of phase 3a trials with once-weekly insulin, icodec, in adults with type 2 diabetes. The on...
Continue Reading →
News

PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments

New facilities offer innovative equipment and increased capacity to bring highly potent oncology therapies to market PHILADELPHIA – July 27, 2022 – PCI Pharma Ser...
Continue Reading →
News

Iconovo receives $883,800 grant from the Bill & Melinda Gates Foundation

Funding will develop inhaled therapies using ICOone Nasal in preparation for the next pandemic. Iconovo has revealed that it has received a grant of $883,800 from...
Continue Reading →
News

MHRA grants marketing authorisation for Global Blood Therapeutics’s Oxbryta

Voxelotor is the first medicine in Britain to directly inhibit sickle haemoglobin polymerisation. Global Blood Therapeutics (GBT) has announced that the Medicines...
Continue Reading →
News

Aurinia receives positive CHMP opinion for Lupkynis

Therapy effectively treats adults with active lupus nephritis in Europe. Aurinia has announced that the Committee for Medicinal Products for Human Use (CHMP) of t...
Continue Reading →
News

Connect in Pharma launches art exhibition and charity partnership to raise funds for rare disease research

Geneva-based event pledges five Swiss francs per visitor to support a new drug development project / Sciad Newswire / The organisers of Connect in Pharma announc...
Continue Reading →
News

New Hampshire Pharmaceutical Development and Clinical Manufacturing Facility Nears Completion

SGS Will Open Its New Facility Near Boston, MA, in August 2022 In August 2022,  SGS's Quay Pharma – our global Center of Excellence for Formulation and Clini...
Continue Reading →
News

TOWER COLD CHAIN SECURES FURTHER INVESTMENT TO SUPERCHARGE ITS SUCCESS

Pharmaceutical temperature-controlled specialist Tower Cold Chain has secured £6.75million in investment, to reinforce the business as the leader in robust, reli...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026